TD ASSET MANAGEMENT INC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 158 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 2.50 and the average weighting 0.3%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$636,000
-10.7%
47,017
-31.6%
0.00%0.0%
Q4 2018$712,000
-81.2%
68,717
-66.5%
0.00%
-83.3%
Q3 2018$3,787,000
-13.4%
205,166
-10.3%
0.01%
-14.3%
Q2 2018$4,372,000
+17.1%
228,683
-5.5%
0.01%
+16.7%
Q1 2018$3,732,000
-24.9%
241,883
-27.1%
0.01%
-14.3%
Q4 2017$4,971,000
-4.9%
331,601
+0.0%
0.01%
-12.5%
Q3 2017$5,229,000
-15.0%
331,583
+1.8%
0.01%
-20.0%
Q2 2017$6,150,000
+10.5%
325,720
-0.2%
0.01%
+11.1%
Q1 2017$5,567,000
+19.0%
326,328
+6.6%
0.01%
+12.5%
Q4 2016$4,679,000
+36.2%
306,028
+41.4%
0.01%
+33.3%
Q3 2016$3,436,000
+35.5%
216,400
+11.6%
0.01%
+20.0%
Q2 2016$2,535,000
+19.5%
193,9000.0%0.01%
+25.0%
Q1 2016$2,121,000
+23.2%
193,900
+30.6%
0.00%
+33.3%
Q4 2015$1,721,000
+8.5%
148,500
-2.4%
0.00%0.0%
Q3 2015$1,586,000
-11.3%
152,200
+2.6%
0.00%0.0%
Q2 2015$1,788,000
+70.9%
148,300
+126.8%
0.00%
+50.0%
Q1 2015$1,046,000
+253.4%
65,400
+238.9%
0.00%
Q4 2014$296,000
+18.4%
19,3000.0%0.00%
Q3 2014$250,000
-15.5%
19,3000.0%0.00%
-100.0%
Q2 2014$296,000
+5.3%
19,300
-15.4%
0.00%0.0%
Q1 2014$281,000
+30.1%
22,800
+22.6%
0.00%
Q4 2013$216,000
-19.4%
18,600
-17.7%
0.00%
-100.0%
Q3 2013$268,000
+36.0%
22,600
+14.1%
0.00%
Q2 2013$197,00019,8000.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$172,422,80022.05%
13D Management LLC 533,562$5,613,0732.85%
Quantedge Capital Pte Ltd 541,200$5,693,4242.22%
Price Jennifer C. 520,000$5,470,4001.74%
Tamarack Advisers, LP 210,000$2,209,2000.81%
Intrinsic Value Partners, LLC 51,605$542,8850.73%
Brown Capital Management 3,933,933$41,384,9750.62%
Old West Investment Management, LLC 75,219$791,3030.43%
EMC Capital Management 43,315$4560.38%
Hillsdale Investment Management Inc. 420,617$4,424,8910.38%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders